SELUTION4BTK Trial

Recruiting now · Not applicable

Conditions studied: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities

In brief

This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

Key facts

Study ID
NCT05055297
Run by
M.A. Med Alliance S.A.
People needed
376
Starts
2022-05-19
Expected to finish
2032-07-30
Last updated by the study team
2026-04-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.